14D. IUSTI Abstracts: Basic and Laboratory Science
Tracks
Track 4
Thursday, September 19, 2024 |
11:00 AM - 12:30 PM |
C2.2 |
Details
Chairs:
Shivani Pasricha, Doherty Institute
Aamirah Mussa, Botswana Harvard Health Partnership / University Of Edinburgh
Shivani Pasricha, Doherty Institute
Aamirah Mussa, Botswana Harvard Health Partnership / University Of Edinburgh
Speaker
Ms Rita Paolini
Team Leader
The University of Melbourne
A 2D in-vitro cell-based model for antimicrobial susceptibility testing against oral gonorrhoea
11:12 AM - 11:24 AMBiography
Ms. Paolini is a Team Leader-Research at the Melbourne Dental School, University of Melbourne. Rita has previously worked as a Research Assistant, accumulating 25 years of experience in university departments, focusing on government and industry-funded projects, particularly in the fields of cell culture, immunology, and microbiology
Dr Shivani Pasricha
Laboratory Head
Doherty Institute
Extending the capability of CRISPR-diagnostics to develop a point-of-care-test for syphilis and herpes simplex virus detection.
11:24 AM - 11:36 AMBiography
Shivani is a Junior laboratory head in the Department of Infectious Diseases, Doherty Institute and an emerging leader in STI research and diagnostic innovation. Shivan's team uses molecular and genomic approaches to improve the detection, prevention, and surveillance of STIs.
Dr Alvaro Borges
Chief Medical Officer
Statens Serum Institut
A phase I double-blind trial investigating trachoma vaccine strategies using the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02)
11:36 AM - 11:48 AMBiography
Álvaro Borges is a infectious diseases physician-scientist educated in Brazil, the United Kingdom and Denmark. He is the chief medical officer at the Center for Vaccine Research (CVR) at Statens Serum Institut in Denmark working on clinical trials testing new candidate vaccines agaisnt chlamydia and tuberculosis in humans.
Dr Stephen Jordan
Assistant Professor Of Medicine
Indiana University
Spontaneous clearance of Chlamydia trachomatis infection is characterized by distinct differences in interferon-gamma-producing memory CD4-T cell populations.
11:48 AM - 12:00 PMBiography
Dr. Jordan is an Assistant Professor of Medicine in the Infectious Diseases Division at Indiana University. As a physician scientist with expertise in the management of nongonococcal urethritis and sexually transmitted infections (STIs), Dr. Jordan treats patients with STIs and oversees a chlamydia translational research program.
Miss Andrea Gillian Abrahams
PhD Student
Division of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, University of Cape Town.
Relationship between bacterial vaginosis and vaginal proteomic profiles of South African adolescent girls and adult women at high risk of HIV acquisition
12:00 PM - 12:12 PMBiography
Andrea Abrahams is a PhD student at the University of Cape Town. Her research focuses on the vaginal metaproteomic profiles of South African adolescent girls and adult women at high risk of HIV infection, with the overarching aim to understand the biological risk factors for HIV acquisition in young women.
IUSTI World Congress
Questions & Discussion
12:12 PM - 12:30 PMBiography
Chair
Aamirah Mussa
Research Fellow
Botswana Harvard Health Partnership / University Of Edinburgh
Shivani Pasricha
Laboratory Head
Doherty Institute
Judges Invited
Kate Seib
Research Leader & Deputy Director
Institute for Glycomics, Griffith University
Barbara Van Der Pol
Professor
University of Alabama at Birmingham Heersink School of Medicine
